Range Resources Corporation (RRC) stock prices updated...
 

Range Resources Corporation stock price, RRC

Range Resources Corporation stock chart:



Range Resources Corporation close price: 25.61

Stock price forecast:

UP TO +0.16%
Target: 25.65

Total forecasts: 90
Reached: 0 (0.00%)

Total Win: 0.00 (0.00%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
No results found.

Showing 1-10 of 624 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-07-2525.6125.660000-00-00
2017-07-2425.6125.650000-00-00
2017-07-2325.6125.650000-00-00
2017-07-2225.6125.650000-00-00
2017-07-2125.6125.650000-00-00
2017-07-2025.6125.660000-00-00
2017-07-1925.6125.660000-00-00
2017-07-1825.6125.660000-00-00
2017-07-1725.6125.650000-00-00
2017-07-1625.6125.660000-00-00

Range Resources Corporation latest news:


  • 07/25/2017 18:42:49

    Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs

    The lawsuit accused the pharmaceutical company of marketing Thalomid and Revlimid for unapproved use on a broader range of cancers.

  • 07/25/2017 15:29:53

    Chegg shares sink after second-quarter loss

    Shares of Chegg Inc. sank in Tuesday's extended session after the online textbook vendor posted a quarterly loss. Chegg reported a second-quarter loss of $6 million, or 6 cents a share, from a loss of $9 million, or 10 cents a share, a year ago. On an adjusted basis, the company would have earned 6 cents a share. Revenue grew 6% to $56.3 million. Analysts surveyed by FactSet had forecast earnings of 4 cents a share on revenue of $53.3 million. Chegg projected third-quarter revenue of $56 million to $58 million and revenue in a range of $241 million to $243 million for the full year. Chegg shares skidded 11% after hours. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/25/2017 15:24:00

    Universal Health Services shares drop on earnings, outlook

    Universal Health Services Inc. shares dropped in the extended session Tuesday after the hospital operator's earnings and outlook fell short of Wall Street estimates. Universal Health Services shares fell 6.4% to $115 after hours. UHS reported second-quarter earnings of $1.76 a share on revenue of $2.85 billion. Analysts surveyed by FactSet had forecast $2.06 a share on revenue of $2.86 billion. UHS lowered their full-year earnings outlook to a range of $7.50 to $8 a share from a previous range of $7.70 to $8.20 a share. Analysts estimated $7.97 a share.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/25/2017 15:06:17

    USANA Health Sciences shares drop after company misses earnings, cuts outlook

    USANA Health Sciences Inc. shares dropped in the extended session Tuesday after the nutritional supplement company's earnings and outlook fell short of Wall Street estimates. USANA shares fell 14% to $55.70 after hours. The company reported second-quarter earnings of 93 cents a share on revenue of $257.1 million. Analysts surveyed by FactSet had estimated earnings of $1.03 a share on revenue of $265.5 million. USANA cut its outlook for the year to a range between $3.50 and $3.70 a share, down from a previous range of $3.80 and $4.10 a share. For the year, analysts had estimated earnings of $4.06 a share.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/25/2017 14:29:36

    BRIEF-Orion Engineered Carbons SA says revenue is expected to be in range of EUR 295 mln-EUR 305 mln for three month ended June 30

    * Orion Engineered Carbons SA - revenue is expected to be in the range of EUR 295 million to eur 305 million for three month period ended June 30, 2017‍​

  • 07/25/2017 14:27:38

    Amgen shares down 3% after company's guidance on lower end of expectations

    Shares of Amgen Inc. fell late Tuesday after the company beat per-share earnings expectations and sales forecasts but provided 2017 guidance on the low end of forecasts. The company said it earned $2.2 billion, or $2.91 a share, in the second quarter, compared with $1.9 billion, or $2.47 a share, in the year-ago period. Adjusted for one-time items, Amgen reported per-share earnings of $3.27, "driven by higher operating margins," it said in a statement. Revenues rose 2% to $5.8 billion, from $5.7 billion a year ago. Analysts polled by FactSet had expected adjusted earnings of $3.11 a share on sales of $5.7 billion. Shares ended the regular session down 0.1%. Amgen also tweaked its 2017 earnings guidance to between $10.79 a share and $11.37 a share and between $12.15 a share and $12.65 a share adjusted. Sales guidance was revised to a range of $22.5 billion and $23 billion. The analysts surveyed by FactSet had expected adjusted 2017 EPS of $12.49 on sales of $22.7 billion for the year. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/24/2017 19:18:51

    Toyota set to sell long-range, fast-charging electric cars in 2022 -paper

    TOKYO, July 25 (Reuters) - Toyota Motor Corp aims to begin selling in 2022 an electric car powered by a new type of battery that significantly increases driving range and reduces recharging time, the Chunichi Shimbun daily reported on Tuesday.

  • 07/24/2017 17:07:51

    BRIEF-Core Lab reports qtrly earnings per share $0.52

    Core Laboratories NV(CLB). * Core Lab reports second quarter 2017 results: * Core Laboratories NV(CLB) - Q2 2017 revenue of $164 million, up 4% sequentially from its Q1 2017 revenue. * Qtrly earnings per share $0.52. * Company projects that its operating income in Q3 is expected to range between $30.9 million and $33.5 million.

  • 07/21/2017 10:16:48

    Bids for Biotoscana Brazil IPO nearly five times supply, sources say

    BOGOTA/SAO PAULO, July 21 (Reuters) - Investors have placed bids worth nearly five times the amount of shares put on sale at the midpoint of a suggested price range for the Brazilian listing of Grupo Biotoscana SA, three people with knowledge of the transaction told Reuters.

  • 07/20/2017 16:49:45

    PetIQ prices initial public offering at high end of range

    PetIQ Inc. said late Thursday that it will price its initial public offering at the high end of its expected range for Friday trade. The distributor of pet medications had priced its IPO of nearly 6.3 million shares at $16 a share. In its filing with the Securities and Exchange Commission, the company had estimated it pricing at $14 and $16 a share. Shares will trade under the ticker "PETQ" on the Nasdaq on Friday.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/20/2017 15:16:54

    Super Micro warns of profit shortfall, stock falls more than 10%

    Super Micro Computer Inc. fell more than 10% in late trading Thursday after disclosing that profit came up short of projections, partly due to the high cost of memory chips. The high-performance computing company said that adjusted profit will be 35 cents to 37 cents a share, lower than previous guidance of 40 cents to 50 cents a share. The announcement noted three causes for a nine-cent downfall per share: "expiring customer agreements with unfavorable DRAM and SSD pricing; urgent new projects with unanticipated R & D expense from major partners with NRE to be recovered in later quarters; and tax impact due to our global corporate tax structure." The cost for dynamic random access memory, or DRAM, and solid-state drives, or SSDs, have spiked in the past year, harming profit for many computer companies. Super Micro said it would report revenue at or above the high end of its previous guidance range of $655 million to $715 million, with expectations for sales now at $712 million to $717 million. Chief Executive Charles Liang promised more details when the company fully reports earnings on Aug. 3. Super Micro stock declined to around $24.15 after closing with a 2.3% increase at $27.10.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/20/2017 14:33:59

    eBay lower as Q2 earnings, sales in line with forecast

    Shares of eBay Inc. fell more than 4% late Thursday after the online auction company reported second-quarter earnings and sales in line with Wall Street expectations. EBay reported a net income from continuing operations of $27 million, or 2 cents a share, compared with $437 million, or 38 cents a share, in the year-ago period. Adjusted for one-time items, eBay earned $493 million, or 45 cents a share, compared with 43 cents a share a year ago. Revenue reached $2.3 billion, compared with $2.2 billion in the second quarter of 2016. The company said it expects third-quarter net revenue between $2.35 billion and $2.39 billion and adjusted per-share earnings from continuing operations in the range of 46 cents to 48 cents. The analysts surveyed by FactSet expect third-quarter per-share earnings of 48 cents a share on sales of $2.32 billion. EBay also said it expects net revenue between $9.3 billion and $9.5 billion for the year, with non-GAAP per-share earnings from continuing operations in the range of $1.98 to $2.03. The same analysts forecast per-share earnings of $2 on sales of $9.4 billion for 2017. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/20/2017 06:27:20

    Sherwin-Williams misses on profit, offers soft outlook as it books charges for Valspar deal

    Shares of paint maker The Sherwin-Williams Co. slid 5.5% Thursday, after the company posted weaker-than-expected profit for the second quarter and offered soft guidance for the full year as it books charges for its acquisition of Valspar. The company said it had net income of $319.1 million, or $3.36 a share, in the second quarter, down from $378.1 million, or $3.99 a share, in the year-earlier period. Adjusted per-share earnings came to $3.80, well below the FactSet consensus of $4.56. The adjusted number includes charges related to the acquisition of Valspar, which closed on June 1. Sales rose 16% to $3.74 billion, just ahead of the FactSet consensus of $3.72 billion. The company said the Valspar deal has led it to change its reporting structure into three new operating segments; the Americas group will house Sherwin-Williams' previous paint stores group and Latin American coatings group; the consumer brands group will house consumer paint businesses of both companies; and the performance coatings group will house Sherwin-Williams' and Valspar's coatings group and automotive refinishes products business. The company said it expects Sherwin-Williams' core net sales to fall by a low to mid single digit percentage in the third quarter. It expects incremental sales from Valspar to be about $1 billion. EPS is expected to range from $3.70 to $4.10 in the quarter, including a $1.10 per share charge related to the acquisition. The current FactSet consensus is for third-quarter EPS of $4.96. For the full year, Sherwin-Williams's sales are expected to fall by a mid single digit percentage compared to 2016, while Valspar sales are expected to total about $2.4 billion. "With annual sales at that level, we are updating our guidance for full year 2017 diluted net income per common share to be in the range of $12.30 to $12.70 per share compared to $11.99 per share earned in 2016," said the company. That includes a $2.50 per share charge for acquisition costs. The current FactSet consensus is for full-year EPS of $14.17. Shares have gained 34% in 2017 through Wednesday, while the S&P 500 has gained 10.5%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/19/2017 15:29:24

    Sarepta shoots higher as sales of $300,000-a-year drug exceed expectations

    Sarepta Therapeutics Inc. shares shot more than 13% higher in late trading Wednesday after the company reported sales of its $300,000-a-year drug for Duchenne muscular dystrophy were better than expected. Sarepta announced second-quarter revenue of $35 million, easily beating the average analyst forecast of $22.5 million, according to a FactSet survey. The company underwent a nearly decade-long effort to get FDA approval for eteplirsen, the first approved treatment for DMD. Sarepta also increased its forecast for full-year revenue, to a range of $125 million to $130 million from previous guidance of more than $95 million. Sarepta stock rose to about $38.80 in late trading, after closing with a 0.6% gain at $34.08; the stock is up more than 61% in the past year, as the S&P 500 index has gained 13.7%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/19/2017 15:17:38

    PTC shares fall after hours on weak outlook

    PTC Inc. shares dropped in the extended session Wednesday after the internet-of-things software company's forecast earnings range fell mostly on the low side of Wall Street estimates. PTC shares fell 11% to $52.49 after hours. The company forecast fiscal fourth-quarter earnings of 33 cents to 38 cents a share on revenue of $303 million to $308 million. Analysts surveyed by FactSet estimate 37 cents a share on revenue of $309 million. The company reported adjusted third-quarter earnings of 28 cents a share on revenue of $291.3 million. Analysts had estimated earnings of 28 cents a share on revenue of $290.6 million.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/18/2017 15:19:00

    UPDATE 3-Carrefour Brasil IPO prices at bottom of range -sources

    BOGOTA/SAO PAULO, July 18 (Reuters) - Grupo Carrefour Brasil SA on Tuesday priced Brazil's largest initial public offering this year at 15 reais per share, the bottom of a suggested price range, two people familiar with the matter said, due to concern over a stretched valuation.

  • 07/17/2017 11:33:07

    Redfin sets IPO terms for up to $1.1 billion valuation

    Real estate brokerage Redfin Corporation set a price range of $12 to $14 a share Monday to raise up to $129 million in its initial public offering. Redfin has an online-offline model in which it lists homes online and also employs real estate agents to bring the customers to the properties. At the high end of its price range, the company would have a public market capitalization of $1.1 billion. The company applied to list its stock on the Nasdaq Global Select Market under the symbol "RDFN." Goldman Sachs & Co. LLC and Allen & Company LLC are the lead underwriters on the offering. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/14/2017 06:09:27

    Global stocks steady as earnings and US data eyed

    Global stock markets are modestly higher in a narrow range as investors await a raft of corporate earnings beginning next week

  • 07/13/2017 16:39:25

    Akcea Therapeutics prices IPO below expected range

    Akcea Therapeutics Inc. priced its initial public offering well below the expected range late Thursday, with shares expected to trade Friday. Akcea priced its 15.6 million share offering at $8 a share, according to IPO Boutique. In late June, the biotech drug developer had forecast an IPO pricing range of $12 to $14 a share for an offering of 9.6 million shares. Akcea shares begin trade on Friday on the Nasdaq under the ticker symbol "AKCA".Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/13/2017 16:02:32

    70 years since Tropicana pioneered mass production of Florida orange juice

    For 70 years, Tropicana has been bringing freshly squeezed orange juice from Florida to grocery stores and kitchen tables across the US.

  • 07/13/2017 14:21:15

    CyberArk shares down 15% as company lowers guidance

    Shares of CyberArk Software Ltd. fell more than 15% late Thursday after the company predicted smaller sales and profits in the second quarter. CyberArk said it expects total revenue in the range of $57 million to $57.5 million, compared with previous guidance $61 million to $62 million. The company forecast GAAP operating income in the range of $700,000 to $1.1 million, and non-GAAP operating income in the range of $8.5 million to $8.9 million, compared to a prior forecast of between $10.9 million and $11.7 million. CyberArk said it will provide full financial results and updated guidance on Aug. 8. CyberArk is "disappointed that our results for the second quarter will be below the guidance we provided in May," CyberArk CEO Udi Mokady said in a statement. The primary reason for the revenue shortfall was the company's performance in the Africa and Middle East region, "where certain deals that we anticipated would close did not close by the end of the quarter," the company said. Shares ended the regular session up 1.1%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/13/2017 11:01:24

    Dallas Fed's Kaplan becomes third FOMC member to question need for more rate hikes

    Dallas Fed President Rob Kaplan on Thursday, in an essay, said he wants to see more evidence of a recovery in inflation before committing to another rate hike. Kaplan, a Federal Open Market Committee member this year, said "at present, with a federal funds rate at a range of 100 to 125 basis points, I would like to see some greater evidence that we are making progress toward meeting our 2% inflation objective in the medium term." He joins Fed. Gov. Lael Brainard in expressing reservation toward more rate hikes. (Minneapolis Fed President Neel Kashkari opposed the June increase.) However, Kaplan does say the plan to reduce the balance sheet "will likely be appropriate" later this year.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/11/2017 09:34:16

    PetIQ sets terms for up to $90.7 million initial public offering

    PetIQ, Inc. , a manufacturer and distributor of pet medications, set a $14 to $16 price range Tuesday to raise up to $90.7 million in its initial public offering. The company plans to sell 5.67 million shares. It recorded a net loss of $3.4 million in 2016 on top of net sales of $200 million. It has applied to list on the Nasdaq Global Market under them symbol "PETQ." Jefferies and William Blair are the lead underwriters on the offering. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/06/2017 14:53:25

    BRIEF-Diebold Nixdorf expects FY revenue in range of $4.7 bln to $4.8 bln

    Diebold Nixdorf Inc(DBD). * Sees FY loss per share on GAAP basis to be $1.65-$1.45. * Diebold Nixdorf Inc(DBD) says it is adjusting its full-year financial outlook for 2017. * Increases its DN2020 net savings target by $40 million to $240 million. * Diebold Nixdorf Inc (DBD) says fullyear revenue is now expected to be in range of $4.7 billion to $4.8 billion.

  • 07/06/2017 12:46:27

    BRIEF-Lockheed Martin awarded $73.8 mln contract for phase 2 of LRPF program

    * Lockheed Martin awarded $73.8m contract for phase 2 of the long range precision fires program

  • 07/05/2017 14:01:18

    North Korean missile advances put new stress on US defenses

    North Korea's newly demonstrated missile muscle puts Alaska within range of potential attack and stresses the Pentagon's missile defenses like never before.

  • 07/05/2017 09:04:47

    Vantiv shares slump almost 4% after Worldpay offer

    Shares of U.S. credit-card processor Vantiv Inc. slumped almost 4% Wednesday after resuming trading following a halt for the news that it has agreed to merger terms with the U.K.'s Worldpay Group Inc. in a deal valued at $10 billion. Worldpay and Vantiv announced the deal early Wednesday, beating out rival J.P. Morgan Chase & Co. , which said shortly after that it would not be making an offer of its own. Vantiv is offering a total of 3.85 pounds in a cash and stock offer that is about 19% above Worldpay's closing price on Monday. Analysts at Stifel said in a note written before the terms were released that a deal would make strategic sense, although they were wary of it coming at too high a price. Speculation on Tuesday had placed the price at a higher range than the one agreed. While PayPal's name was not mentioned in any of the coverage of the deal on Tuesday, "we think it makes sense strategically and wouldn't be surprised to see PYPL enter the fray," they wrote. PayPal shares were last up 2%. Vantiv shares have gained 1.4% in 2017, while the S&P 500 has gained 8.6%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • 07/04/2017 11:34:56

    Global shares stumble, oil steadies after flying start to second half

    LONDON (Reuters) - World shares pulled back and bonds and gold regained favor on Tuesday as a long-range ballistic missile test by North Korea and July 4 holidays for U.S. markets dampened risk appetite.

  • 07/03/2017 17:06:39

    Subway targets 3,000 UK/Ireland stores by 2020

    The Subway franchise of sandwich restaurants plans to open a further 500 outlets in the UK and Ireland over the next three years, creating about 5,000 jobs, as it seeks to capitalize on a growing appetite for cheap food on the go. Subway, which sells a wide range of freshly made submarine sandwiches, as well as salads, said on Tuesday it was targeting 3,000 stores by 2020, up from 2,500 currently.

  • 07/03/2017 11:22:44

    BRIEF-Staff One HR partners with Aetna to offer a master medical plan to national marketplace

    Staff One HR: * Has partnered with Aetna to offer a master medical plan to national marketplace. * Will offer its clients a variety of plan designs, featuring low, mid-range and high deductibles Source text for Eikon: Further company coverage:

  • More trends:

    Raymond James FinancialRJD | Raymond James FinancialRJF | Rayonier Advanced Materials Inc.RYAM | Rayonier Inc.RYN | Raytheon CompanyRTN | RCS CAPITAL CORPORATIONRCAP | RE/MAX HoldingsRMAX | RealD IncRLD | Realogy Holdings Corp.RLGY | Realty Income CorporationO |